Dec 24 (Reuters) - Sanofi (SASY.PA) said on Wednesday it will buy U.S. biotech Dynavax Technologies (DVAX.O) for around $2.2 ...

I don’t want to be stuck in a box,” says a Tauranga woman suffering from a hereditary muscular disorder. “Stuck in a box” is ...

In November 2025, Epicrispr Biotechnologies Inc. announced a clinical trial is to learn how safe and tolerable EPI-321 is and ...

Muscular Dystrophy is a condition marked by progressive weakening and wasting of the muscles, including the heart and lungs, ...

Myotonic dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy, affecting about 1 in 8,000 people.

An alumnus of a school in Patran, Singla completed his bachelor’s degree in law from Hisar and is currently pursuing a master ...

Grants include research funding in amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth disease (CMT), Duchenne muscular ...

The US HHS has added Duchenne muscular dystrophy and metachromatic leukodystrophy to newborn screening, citing benefits of early detection and access to FDA-approved treatments.

As of Wednesday, December 24, Edgewise Therapeutics, Inc.’s EWTX share price has surged by 20.17%, which has investors questioning if this is right time to sell.

Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic ...

Muscular dystrophy is a set of genetic diseases that cause muscles to become progressively weaker. Many forms of the disease ...